Octapharma gets FDA approval for immune thrombocytopenic purpura therapy Octagam 10%
Octagam 10% [immune globulin intravenous (human) 10% (100mg/ml) liquid preparation] helps in rapidly raising platelet counts to control or prevent bleeding in chronic ITP patients. The FDA approval